WKN: | A0LA5K |
ISIN: | SE0000872095 |
Land: | Schweden |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Swedish Orphan Biovi-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 05. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2012 | 1,59 | 4,25 | 167,30% |
2 | 2015 | 8,32 | 14,61 | 75,60% |
3 | 2013 | 4,25 | 7,39 | 73,88% |
4 | 2010 | 2,40 | 4,04 | 68,33% |
5 | 2018 | 11,32 | 18,44 | 62,90% |
6 | 2009 | 1,75 | 2,40 | 37,14% |
7 | 2023 | 19,20 | 24,14 | 25,73% |
8 | 2024 | 24,14 | 27,66 | 14,58% |
9 | 2014 | 7,39 | 8,32 | 12,58% |
10 | 2021 | 16,12 | 17,70 | 9,80% |
11 | 2020 | 14,79 | 16,12 | 8,99% |
12 | 2022 | 17,70 | 19,20 | 8,47% |
13 | 2017 | 11,11 | 11,32 | 1,89% |
14 | 2025 | 27,66 | 25,46 | -7,95% |
15 | 2019 | 18,44 | 14,79 | -19,79% |
16 | 2016 | 14,61 | 11,11 | -23,96% |
17 | 2007 | 5,49 | 3,32 | -39,53% |
18 | 2008 | 3,32 | 1,75 | -47,29% |
19 | 2011 | 4,04 | 1,59 | -60,64% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2011 | 4,04 | 1,59 | -60,64% |
2 | 2008 | 3,32 | 1,75 | -47,29% |
3 | 2007 | 5,49 | 3,32 | -39,53% |
4 | 2016 | 14,61 | 11,11 | -23,96% |
5 | 2019 | 18,44 | 14,79 | -19,79% |
6 | 2025 | 27,66 | 25,46 | -7,95% |
7 | 2017 | 11,11 | 11,32 | 1,89% |
8 | 2022 | 17,70 | 19,20 | 8,47% |
9 | 2020 | 14,79 | 16,12 | 8,99% |
10 | 2021 | 16,12 | 17,70 | 9,80% |
11 | 2014 | 7,39 | 8,32 | 12,58% |
12 | 2024 | 24,14 | 27,66 | 14,58% |
13 | 2023 | 19,20 | 24,14 | 25,73% |
14 | 2009 | 1,75 | 2,40 | 37,14% |
15 | 2018 | 11,32 | 18,44 | 62,90% |
16 | 2010 | 2,40 | 4,04 | 68,33% |
17 | 2013 | 4,25 | 7,39 | 73,88% |
18 | 2015 | 8,32 | 14,61 | 75,60% |
19 | 2012 | 1,59 | 4,25 | 167,30% |